DUBLIN, Nov. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Acne Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient's quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne.
The analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018.
The Global Acne market can be divided into seven segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Implications of Acne
08. Types and Characteristics of Acne
09. Competitive Assessment of Marketed Products
10. Rate of Incidence and Prevalence
11. Market Segmentation by Category
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
21. Key Vendor Analysis
Companies Mentioned:
- Actavis
- Allergen
- Galderma
- Stiefel
- Valeant
- Andro Science
- Bayer
- Cipher
- Cosmo
- Elorac
- Foamix
- Helix BioMedix
- Hygeia
- IMTM
- J&J
- Mylan
- NanoBio
- NovaLead Pharma
- F. Hoffmann-La Roche
For more information visit http://www.researchandmarkets.com/research/g5cms9/global_acne
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
